BFS
RYTM icon

Bare Financial Services’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bare Financial Services’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$888 Sell
8
-5
-38% -$452 ﹤0.01% 1424
2026
Q1 		$1.13K Sell
13
-9
-41% -$875 ﹤0.01% 1192
2025
Q4 		$2.35K Buy
22
+4
+22% +$424 ﹤0.01% 807
2025
Q3 		$1.82K Buy
18
+8
+80% +$743 ﹤0.01% 835
2025
Q2 		$632 Buy
+10
New +$612 ﹤0.01% 1051

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bare Financial Services's RYTM Position: Q2 2026 in Review

Bare Financial Services reduced its Rhythm Pharmaceuticals (RYTM) stake by 38% in Q2 2026, selling an estimated $452 and leaving 8 shares worth $888. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

Bare Financial Services first reported a position in RYTM in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.35K in Q4 2025. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Bare Financial Services held 8 shares of Rhythm Pharmaceuticals worth $888 as of Q2 2026.
  • Bare Financial Services sold 5 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $452.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1424 holding.
  • Bare Financial Services first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Bare Financial Services's Rhythm Pharmaceuticals position peaked at $2.35K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.